稳定的生物催化剂应用的不移
Karolina Labus1, Aleksandra Lambarska2, Katarzyna Czyżewska1
1Department of Micro, Nano and Bioprocess Engineering, Wrocław University of Science and Technology, C.K. Norwida 4/6, Wrocław, Poland.
Methods in enzymology
|April 27, 2025
概括
酶固定是创造稳定的生物催化剂的关键. 本综述涵盖了各种固定化技术,它们的优缺点,以及选择合适的方法和载体的因素.
科学领域:
- 生物催化和酶工程 生物催化和酶工程
- 生物技术中的材料科学
- 化学和生物化学工程 化学和生物化学工程
背景情况:
- 酶的稳定性和可重复使用性对于高效的生物催化剂至关重要.
- 固定化技术可以提高酶的性能和运行稳定性.
- 对于实际应用,需要对固定方法有全面的了解.
研究的目的:
- 审查和比较主要的酶固定化策略.
- 讨论依赖支持和不依赖支持的方法的优缺点.
- 为选择合适的载体和反应堆设计提供固定化指导.
主要方法:
- 关于酶固定化技术的文献综述.
- 方法分为基于支的 (吸附,共价结合,金属结合,捕获) 和没有支的 (交联,反应堆体积) 的方法.
- 讨论载体材料的特性和选择标准.
主要成果:
- 固定可显著提高生物催化剂的稳定性,并促进重复使用.
- 基于支持的方法提供多种交互机制,而无支持的方法提供更简单的方法.
- 成功固定化的关键因素包括载体特性,方法选择和反应堆设计.
结论:
- 有效的酶固定是开发强大的和经济的生物催化工艺的关键.
- 固定方法和载体的选择取决于特定的酶和应用.
- 优化固定参数和反应堆配置对于最大限度地提高生物催化剂效率至关重要.
更多相关视频
14:43Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications
Published on: September 23, 2013
10.7K
09:27Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability
Published on: April 22, 2016
17.2K
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Bioreactor Design and Operational System
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
Bioreactor Controls-II
In aerobic fermentations, oxygen is vital for microbial growth and metabolite production. Since air comprises only about 20% oxygen and the gas is poorly soluble in water—just 9 ppm at 20°C—supplying sufficient oxygen becomes a critical challenge, especially in high-demand processes like yeast growth or citric acid production. Even a fully saturated broth may offer only a few seconds of oxygen availability.To address this, sterile or scrubbed air is introduced into the fermentor via a sparger...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
